The safety and efficacy of dose-sparing intradermal administration of influenza vaccine in human immunodeficiency virus-positive patients.
Khanlou
Homayoon
H
Sanchez
Susan
S
Babaie
Michele
M
Chien
Catherine
C
Hamwi
Gerald
G
Ricaurte
Juan-Carlos
JC
Stein
Tomiko
T
Bhatti
Laveeza
L
Denouden
Paul
P
Farthing
Charles
C
D000328:Adult; D000368:Aged; D000554:Ambulatory Care Facilities; D000914:Antibodies, Viral / Q000097:blood; D002140:California / Q000453:epidemiology; D005260:Female; D015658:HIV Infections / Q000453:epidemiology*; D006801:Humans; D009980:Influenza A virus / Q000276:immunology*; D009981:Influenza B virus / Q000276:immunology*; D007252:Influenza Vaccines / Q000008:administration & dosage*; D007251:Influenza, Human / Q000276:immunology / Q000517:prevention & control*; D007271:Injections, Intradermal; D007273:Injections, Intramuscular; D008297:Male; D008875:Middle Aged
D000914:Antibodies, Viral; D007252:Influenza Vaccines